A simple and rapid method for measuring neuroleptic drugs in plasma by the estimation of dopamine receptor blocking activity is described. The assay has the advantages that it can be used without modification for all neuroleptic drugs and measures both parent compound as well as pharmacologically active metabolites.
展开▼